Q4 GDP-prelim -6.2% vs -5.4% consensus, prior -3.8%
Nominaalne GDP tuli tegelikkult ootusele vastav. Härrased LHVs, vaadake deflaatorit kah ning andke väike kommentaar.
USA alustab päeva uute 52 nädala põhjade jurues, tähtsamad indeksid ca 1.5% kuni 2% punases.
Saksamaa DAX -3.71%
Prantsusmaa CAC 40 -2.99%
Inglismaa FTSE 100 -3.16%
Hispaania IBEX 35 -3.23%
Venemaa MICEX -2.42%
Poola WIG -0.82%
Aasia turud:
Jaapani Nikkei 225 +1.48%
Hong Kongi Hang Seng -0.65%
Hiina Shanghai A (kodumaine) -1.80%
Hiina Shanghai B (välismaine) -4.34%
Lõuna-Korea Kosdaq +1.27%
Tai Set 50 +0.13%
India Sensex 30 -0.71%
Markets Point Lower on Citi News
By Rev Shark
RealMoney.com Contributor
2/27/2009 8:07 AM EST
It is not necessary to hope in order to understand, nor to succeed in order to persevere.
-- Charles the Bold
The economy and the stock market continue to look extremely grim. We have had a series of governmental initiatives in the last couple of weeks that have been unable to turn the steady collapse of the market.
This morning we have news of a major government investment in Citigroup (C) . This has been widely expected for a while, but the terms appear to be more dilutive than expected and the stock is down sharply in premarket trading. In addition, other major banks including Bank of America (BAC) , Wells Fargo (WFC) and JPMorgan (JPM) are trading down in sympathy. It looks like quasi-nationalization is occurring, and the market has yet to effectively price it.
In addition to the continued and steady negative news flow, the charts of the major indices are just barely holding on. The S&P 500 bounced off the November lows a couple days ago but after the intraday reversal yesterday and the poor news this morning, it looks like it will crack that level again. It is possible that we will find some footing here, but the conditions strongly suggest a further breakdown at this point.
We don't need to spend a lot of time trying to understand what is going on out there. It is obvious that we are undergoing a tremendous economic upheaval, and we can't base an investment strategy on hope that it will come to an end in the next few days or weeks. We have to persevere and simply let this play out. The absolute best thing we can do is protect our capital.
I am greatly frustrated when I see people write about how they are sure a great market reversal is coming soon and that this meltdown is a fantastic opportunity. They ignore the fact that there has been no sign of a change in the trend. They latch on to minor details to try to convince us that their predictions will be correct.
It is fascinating how difficult it is for so many market players to simply respect and defer to the action that is right in front of them. If a powerful force that we can't possibly influence personally is acting in a certain manner, it just doesn't do any good to argue with it. Sure, it might change its mind and reverse, but it isn't going to happen because of anything we think or do.
The market is an irrational beast, and as I've often said, it will almost always trend one way or the other far more than we think is reasonable. Trusting it to change its behavior is a very easy way to lose money.
The banks are accelerating to the downside as I write. This may finally be the market recognition of the fact that the common stock in many of these banks are close to worthless as more ownership shifts to the government. It isn't nationalization, but it is starting to feel like it.
The good news is that we are getting the bad news out there. It is going to an eventful day. Just don't forget that capital preservation is your No. 1 job.
-----------------------------
Ülespoole avanevad:
In reaction to strong earnings/guidance: MGI +21.5%, BCSI +14.1%, BARE +13.2%, INT +9.8%, UHS +7.4%, OUTD +5.5%, DTSI +5.4% (upgraded to Buy at Kaufman Bros), HGSI +4.6% (also upgraded to Accumulate at ThinkEquity), ANAD +4.4%, MGLN +4.2% (light volume), WCRX +4.1% (light volume), DELL +1.2%... M&A news: CVTX +2.5% (Astellas Pharma announced that its indirect subsidiary, Sturgeon Acquisition, has commenced a cash tender offer for all outstanding shares of common stock of CV Therapeutics at a price of $16.00 per share)... Select gold related names showing strength: AUY +2.4%, GG +2.1%, EGO +2.0%, KGC +1.9%, ABX +1.9%, AEM +1.7% (upgraded to Outperform from Market Perform at Raymond James)... Other news: PBT +15.1% (Cramer makes positive comments on MadMoney), MIC +11.7% (modestly rebounding following yesterday's 40%+drop), CEPH +5.0% (launches takeover for Australian biotech Arana Therapeutics), TWC +3.6% (announces $10.27 special dividend and reverse split as part of separation from Time Warner)... Analyst comments: CHS +6.4% (upgraded to Outperform at Friedman Billings), ANSS +2.2% (light volume; upgraded to Buy at Jefferies).
Allapoole avanevad:
In reaction to disappointing earnings/guidance: ERES -21.2%, CTV -16.5%, JRCC -16.4%, DECK -13.5%, OVTI -12.0%, ADSK -9.7% (also downgraded to Hold at KeyBanc), RWT -8.0%, CVA -6.7%, KSS -5.5%, GPS -4.8%, SWN -1.9%... Select financial related names trading sharply lower: C -39.4% ( exchange preferred securities for common, increasing tangible common equity to as much as $81 bln; suspends dividends; announces it will have a majority of new independent directors as soon as feasible), BAC -18.2%, LYG -18.0% (talks not expected to advance Friday; talks with UK govt on insuring assets to resume Monday, according to source - WSJ), PFG -17.5% (hearing added to Conviction Sell List at tier 1 firm), LNC -14.0% (S&P lowers ratings on U.S. Life Insurer Groups because of stressed assets), RBS -13.8%, CIT -12.7%, AIB -12.6%, WFC -12.2%, ING -10.5%, HIG -9.6% (S&P lowers ratings on U.S. Life Insurer Groups because of stressed assets), USB -8.9%, MET -8.3% (S&P lowers ratings on U.S. Life Insurer Groups because of stressed assets), SLM -7.9% (target lowered to $10 at Credit Suisse and downgraded to Equal Weight at Barclays), PRU -7.8%, PNC -6.7%, COF -6.0%, STT -5.8%, JPM -5.5%, XL -4.8% (announces tender offer for Series C preference ordinary shares), HCBK -4.7%, UBS -4.6% (Changes at UBS may not be over - NY Post), HBC -4.4%, STD -3.8%, GS -3.6%, BBT -3.2%... Select drug related names under continued pressure: BMY -4.6%, AZN -4.6% (FDA asks AstraZeneca for more data on Seroquel XR - DJ), MRK -3.8%, SNY -2.4%, ABT -1.7%, GSK -1.6%... Select metals/mining names showing weakness: FCX -5.3%, BHP -4.6%, BBL -3.6%, MT -3.6%, RIO -3.4%... Select oil/gas related names trading lower with weakness in crude: PBR -4.5%, BTU -3.8%, SLB -3.1%, PTR -2.8%, BP -2.1%, XOM -2.0%, CVX -1.9%, RDS.A -1.5%, COP -1.2%, TOT -1.0%... Other news: SNTA -72.6% (suspends Elesclomol SYMMETRYSM Trial in metastatic melanoma; also downgraded to Hold at Lazard Capital, downgraded to Sector Perform at RBC, downgraded to Mkt Perform at Rodman & Renshaw and downgraded to Underperform at Wachovia), SOMX -62.1% (receives complete response letter from the FDA for Silenor and downgraded to Hold at Natixis), PKG -12.2% (reduces quarterly dividend to $0.15/share from $0.30/share; also downgraded to Hold at Deutsche Securities), MGM -10.1% (discloses that it requests to borrow $842 mln from $4.5 bln credit pact), GM -8.4% (State Of Hesse's Koch implies help for Opel investors, according to report - DJ), HK -6.6% (announces public offering of 22 mln shares of common stock), DRYS -6.5% (still checking), CME -3.1% (in talks to launch derivatives clearer in London - FT)... Analyst comments: PAYX -9.4% (downgraded to Sell at Goldman - Reuters), FII -7.0% (downgraded to Conviction List Sell from Neutral at Goldman- Reuters), SNDA -6.1% (downgraded to Underperform at Credit Suisse), ADBE -6.0% (downgraded to Market Perform at Wachovia), CLF -5.5% (downgraded to Hold at KeyBanc Capital Mkts), RTP -3.2% (cut to Sell from Neutral by Goldman Sachs- DJ).
By Rev Shark
RealMoney.com Contributor
2/27/2009 8:07 AM EST
It is not necessary to hope in order to understand, nor to succeed in order to persevere.
-- Charles the Bold
The economy and the stock market continue to look extremely grim. We have had a series of governmental initiatives in the last couple of weeks that have been unable to turn the steady collapse of the market.
This morning we have news of a major government investment in Citigroup (C) . This has been widely expected for a while, but the terms appear to be more dilutive than expected and the stock is down sharply in premarket trading. In addition, other major banks including Bank of America (BAC) , Wells Fargo (WFC) and JPMorgan (JPM) are trading down in sympathy. It looks like quasi-nationalization is occurring, and the market has yet to effectively price it.
In addition to the continued and steady negative news flow, the charts of the major indices are just barely holding on. The S&P 500 bounced off the November lows a couple days ago but after the intraday reversal yesterday and the poor news this morning, it looks like it will crack that level again. It is possible that we will find some footing here, but the conditions strongly suggest a further breakdown at this point.
We don't need to spend a lot of time trying to understand what is going on out there. It is obvious that we are undergoing a tremendous economic upheaval, and we can't base an investment strategy on hope that it will come to an end in the next few days or weeks. We have to persevere and simply let this play out. The absolute best thing we can do is protect our capital.
I am greatly frustrated when I see people write about how they are sure a great market reversal is coming soon and that this meltdown is a fantastic opportunity. They ignore the fact that there has been no sign of a change in the trend. They latch on to minor details to try to convince us that their predictions will be correct.
It is fascinating how difficult it is for so many market players to simply respect and defer to the action that is right in front of them. If a powerful force that we can't possibly influence personally is acting in a certain manner, it just doesn't do any good to argue with it. Sure, it might change its mind and reverse, but it isn't going to happen because of anything we think or do.
The market is an irrational beast, and as I've often said, it will almost always trend one way or the other far more than we think is reasonable. Trusting it to change its behavior is a very easy way to lose money.
The banks are accelerating to the downside as I write. This may finally be the market recognition of the fact that the common stock in many of these banks are close to worthless as more ownership shifts to the government. It isn't nationalization, but it is starting to feel like it.
The good news is that we are getting the bad news out there. It is going to an eventful day. Just don't forget that capital preservation is your No. 1 job.
-----------------------------
Ülespoole avanevad:
In reaction to strong earnings/guidance: MGI +21.5%, BCSI +14.1%, BARE +13.2%, INT +9.8%, UHS +7.4%, OUTD +5.5%, DTSI +5.4% (upgraded to Buy at Kaufman Bros), HGSI +4.6% (also upgraded to Accumulate at ThinkEquity), ANAD +4.4%, MGLN +4.2% (light volume), WCRX +4.1% (light volume), DELL +1.2%... M&A news: CVTX +2.5% (Astellas Pharma announced that its indirect subsidiary, Sturgeon Acquisition, has commenced a cash tender offer for all outstanding shares of common stock of CV Therapeutics at a price of $16.00 per share)... Select gold related names showing strength: AUY +2.4%, GG +2.1%, EGO +2.0%, KGC +1.9%, ABX +1.9%, AEM +1.7% (upgraded to Outperform from Market Perform at Raymond James)... Other news: PBT +15.1% (Cramer makes positive comments on MadMoney), MIC +11.7% (modestly rebounding following yesterday's 40%+drop), CEPH +5.0% (launches takeover for Australian biotech Arana Therapeutics), TWC +3.6% (announces $10.27 special dividend and reverse split as part of separation from Time Warner)... Analyst comments: CHS +6.4% (upgraded to Outperform at Friedman Billings), ANSS +2.2% (light volume; upgraded to Buy at Jefferies).
Allapoole avanevad:
In reaction to disappointing earnings/guidance: ERES -21.2%, CTV -16.5%, JRCC -16.4%, DECK -13.5%, OVTI -12.0%, ADSK -9.7% (also downgraded to Hold at KeyBanc), RWT -8.0%, CVA -6.7%, KSS -5.5%, GPS -4.8%, SWN -1.9%... Select financial related names trading sharply lower: C -39.4% ( exchange preferred securities for common, increasing tangible common equity to as much as $81 bln; suspends dividends; announces it will have a majority of new independent directors as soon as feasible), BAC -18.2%, LYG -18.0% (talks not expected to advance Friday; talks with UK govt on insuring assets to resume Monday, according to source - WSJ), PFG -17.5% (hearing added to Conviction Sell List at tier 1 firm), LNC -14.0% (S&P lowers ratings on U.S. Life Insurer Groups because of stressed assets), RBS -13.8%, CIT -12.7%, AIB -12.6%, WFC -12.2%, ING -10.5%, HIG -9.6% (S&P lowers ratings on U.S. Life Insurer Groups because of stressed assets), USB -8.9%, MET -8.3% (S&P lowers ratings on U.S. Life Insurer Groups because of stressed assets), SLM -7.9% (target lowered to $10 at Credit Suisse and downgraded to Equal Weight at Barclays), PRU -7.8%, PNC -6.7%, COF -6.0%, STT -5.8%, JPM -5.5%, XL -4.8% (announces tender offer for Series C preference ordinary shares), HCBK -4.7%, UBS -4.6% (Changes at UBS may not be over - NY Post), HBC -4.4%, STD -3.8%, GS -3.6%, BBT -3.2%... Select drug related names under continued pressure: BMY -4.6%, AZN -4.6% (FDA asks AstraZeneca for more data on Seroquel XR - DJ), MRK -3.8%, SNY -2.4%, ABT -1.7%, GSK -1.6%... Select metals/mining names showing weakness: FCX -5.3%, BHP -4.6%, BBL -3.6%, MT -3.6%, RIO -3.4%... Select oil/gas related names trading lower with weakness in crude: PBR -4.5%, BTU -3.8%, SLB -3.1%, PTR -2.8%, BP -2.1%, XOM -2.0%, CVX -1.9%, RDS.A -1.5%, COP -1.2%, TOT -1.0%... Other news: SNTA -72.6% (suspends Elesclomol SYMMETRYSM Trial in metastatic melanoma; also downgraded to Hold at Lazard Capital, downgraded to Sector Perform at RBC, downgraded to Mkt Perform at Rodman & Renshaw and downgraded to Underperform at Wachovia), SOMX -62.1% (receives complete response letter from the FDA for Silenor and downgraded to Hold at Natixis), PKG -12.2% (reduces quarterly dividend to $0.15/share from $0.30/share; also downgraded to Hold at Deutsche Securities), MGM -10.1% (discloses that it requests to borrow $842 mln from $4.5 bln credit pact), GM -8.4% (State Of Hesse's Koch implies help for Opel investors, according to report - DJ), HK -6.6% (announces public offering of 22 mln shares of common stock), DRYS -6.5% (still checking), CME -3.1% (in talks to launch derivatives clearer in London - FT)... Analyst comments: PAYX -9.4% (downgraded to Sell at Goldman - Reuters), FII -7.0% (downgraded to Conviction List Sell from Neutral at Goldman- Reuters), SNDA -6.1% (downgraded to Underperform at Credit Suisse), ADBE -6.0% (downgraded to Market Perform at Wachovia), CLF -5.5% (downgraded to Hold at KeyBanc Capital Mkts), RTP -3.2% (cut to Sell from Neutral by Goldman Sachs- DJ).
Kas mitte kõik rootsi pangad ei kuulu ühele perekonnale ?
rootsi kunnile?
Mis on Eesti, Läti ja Leedu CDSide tickerid Bloombergis või kuidas ned leida?
Fed's Plosser says must ensure credit policies don't hamper ability to conduct further monetary policy - Reuters
Fed's Rosengren says economy to shrink 'significantly' in 1H 2009 - DJ
momentum, mina olen neid vaadanud muidu Bloombergi terminalist - trükkides sisse lihtsalt CDS Estonia, valides sealt government/state ning 5-year EUR CDS... Ma ei teagi praegu, kas seda oleks võimalik ka www.bloomberg.com lehelt leida või mitte...
Fed's Plosser says Fed still open to buying long term treasury bonds - Reuters
Ja juba varem välja tulnud uudis GE-lt:
General Electric to cut qtrly dividend to $0.10 from $0.31- CNBC
S&P kohe kommiga ka väljas:
General Electric: S&PBulletin says GE ratings, outlook unchanged after dividend cut
Ja juba varem välja tulnud uudis GE-lt:
General Electric to cut qtrly dividend to $0.10 from $0.31- CNBC
S&P kohe kommiga ka väljas:
General Electric: S&PBulletin says GE ratings, outlook unchanged after dividend cut
Citigroup (C): S&P revises Citigroup outlook to negative, downgrades hybrids
C aktsiat on hetkel kaubeldud 1.486 miljardit, ühtlasi vist kõikide aegade suurim käive.
C aktsiat on hetkel kaubeldud 1.486 miljardit, ühtlasi vist kõikide aegade suurim käive.
SPX and Dow set to close at their lowest levels since 1997... currently SPX -16.7 at 737.14 and Dow -100.91 at 7076.15